Literature DB >> 8017896

Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis.

D W Paty1, D K Li, J J Oger, L Kastrukoff, R Koopmans, E Tanton, G J Zhao.   

Abstract

Magnetic resonance imaging (MRI) provides an objective method of evaluating multiple sclerosis clinical trials and is at least five times more sensitive to disease activity. In a recent clinical trial, MRI was also approximately twice as sensitive as clinical measurements to the treatment effect of a drug.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8017896     DOI： 10.1002/ana.410360721

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


  12 in total

1.  FLAIR2: A Combination of FLAIR and T2 for Improved MS Lesion Detection.

Authors:  V Wiggermann; E Hernández-Torres; A Traboulsee; D K B Li; A Rauscher
Journal:  AJNR Am J Neuroradiol       Date:  2015-10-08       Impact factor: 3.825

Review 2.  Magnetic resonance spectroscopy in vivo: applications in neurological disorders.

Authors:  D L Arnold; N De Stefano
Journal:  Ital J Neurol Sci       Date:  1997-12

Review 3.  Magnetic resonance imaging of multiple sclerosis lesions. Measuring outcome in treatment trials.

Authors:  J H Simon
Journal:  West J Med       Date:  1996-06

Review 4.  Mechanisms of action of interferon-beta in multiple sclerosis.

Authors:  B G Arnason; A Dayal; Z X Qu; M A Jensen; K Genç; A T Reder
Journal:  Springer Semin Immunopathol       Date:  1996

Review 5.  Magnetic resonance in monitoring the natural history of multiple sclerosis and the effects of treatment.

Authors:  M Filippi; M Rovaris; G Comi
Journal:  Ital J Neurol Sci       Date:  1996-12

6.  An algorithm for automatic segmentation and classification of magnetic resonance brain images.

Authors:  B J Erickson; R T Avula
Journal:  J Digit Imaging       Date:  1998-05       Impact factor: 4.056

7.  Ultrashort echo time (UTE) magnetic resonance imaging of myelin: technical developments and challenges.

Authors:  Ya-Jun Ma; Hyungseok Jang; Eric Y Chang; Annie Hiniker; Brian P Head; Roland R Lee; Jody Corey-Bloom; Graeme M Bydder; Jiang Du
Journal:  Quant Imaging Med Surg       Date:  2020-06

8.  Paranodal myelin retraction in relapsing experimental autoimmune encephalomyelitis visualized by coherent anti-Stokes Raman scattering microscopy.

Authors:  Yan Fu; Terra J Frederick; Terry B Huff; Gwendolyn E Goings; Stephen D Miller; Ji-Xin Cheng
Journal:  J Biomed Opt       Date:  2011-10       Impact factor: 3.170

9.  A Model of Population and Subject (MOPS) Intensities With Application to Multiple Sclerosis Lesion Segmentation.

Authors:  Xavier Tomas-Fernandez; Simon K Warfield
Journal:  IEEE Trans Med Imaging       Date:  2015-01-19       Impact factor: 10.048

Review 10.  MRI: role in optimising treatment.

Authors:  Anthony Traboulsee
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.